Celsion Corporation Share Price Nasdaq
Equities
US15117N4043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
05-13 | Transcript : Imunon, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
05-08 | IMUNON, Inc. Appoints Stacy R. Lindborg as Chief Executive Officer, Effective May 13, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 12.88M 1.01B |
---|---|---|---|---|---|
Net income 2024 * | -21M -1.65B | Net income 2025 * | -25M -1.97B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.65
x | P/E ratio 2025 * |
-0.84
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.85% |
Latest transcript on Celsion Corporation
Managers | Title | Age | Since |
---|---|---|---|
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 03/06/21 |
Michael Tardugno
CHM | Chairman | 73 | 02/01/07 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 05/07/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 07/06/21 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 07/07/11 |
James Dentzer
BRD | Director/Board Member | 57 | 02/09/22 |
1st Jan change | Capi. | |
---|---|---|
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |